BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Lymphocyte, Laser capture microdissection, Aspirin, rs6983267, PTEN, Arthritis)
Bookmark Forward

QuickView for LAG3 (gene)


Body Atlas

Most Correlated Tissues

  1. T Lymphocyte (CD8+) of peripheral blood
  2. Natural killer cell of peripheral blood
  3. T Lymphocyte (regulatory) of peripheral blood
  4. Appendix
  5. T Lymphocyte (CD4+) of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Meningitis
  2. Viral infections of the central nervous system
  3. Malaria
  4. Epstein-Barr virus disease
  5. Protozoan infection
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. grass pollen extract, alum-adsorbed
  2. OVA-8
  3. IL2 protein, human
  4. 5'PPP-RNA
  5. CL097 compound
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. HOXC13-AS
  2. SPOP
  3. PEX5
  4. ARHGAP5
  5. Sle1c
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy.
  2. LAG3 in gastric cancer: it's complicated.
  3. Lymphocyte-Activation Gene 3 Facilitates Pathological Tau Neuron-to-Neuron Transmission.
  4. Diminished LAG3+ B cells correlate with exacerbated rheumatoid arthritis.
  5. Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in canc…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) in Treating Melanoma Prior Immune Checkpoint In…
  2. LAG3 PET Imaging in Advanced Solid Tumors
  3. Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic …
  4. Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanom…
  5. Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.